Monsters of the Midway
UChicago licensee NephRx is moving swiftly to bring to market therapeutics for patients with kidney transplants and mucositis. Nephrology professor Gary Toback, MD, PhD (left) developed the therapies that have attracted the interest of three large pharmaceutical companies according… Keep reading